For the second year, this research award will provide the opportunity for one individual to leverage NanoString Technologies’ GeoMx® Digital Spatial Profiler (DSP) to perform highly multiplexed, whole transcriptome spatial profiling of RNA and up to 80-plex protein profiling. Applicants will be encouraged to submit their proposals for a cancer immunotherapy project that can utilize the spatial profiling technology to advance their research. The most impactful proposal for cancer immunotherapy research will be selected. The application period for this award is now closed.
Eligibility Criteria
- Hold a PhD degree or combined MD, PhD degree (practicing physicians are not eligible to apply)
- Currently hold a position at an academic cancer center as a postdoctoral fellow, research scientist or comparable position
- Be a SITC member in good standing at time of submission (i.e., current in dues)
- Applicable regulatory (local or central IRB) approval
- Award recipient and award recipient’s institution agree to the research award program terms and conditions as a condition of award acceptance
- Award recipient and recipient’s institution agree in writing to NanoString Technologies' terms as a condition of award acceptance
Benefits
This award will provide $25,000 of “in-kind” support to allow the awardee up to 5 FFPE samples, with up to 12 Regions of Interest (ROI)/samples to be run on GeoMx® DSP using the GeoMx® Whole Transcriptome Atlas Assay and GeoMx Protein assays, for both RNA and Protein. Content covers the most relevant targets for understanding tumor and tumor microenvironment biology. The awardee will be invited to a virtual meeting with Nanostring’s leadership and scientific teams. NanoString will be responsible for the shipment of samples between the awardee’s institution and the NanoString facility.